Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enarodustat + Cyclosporine vs Cyclosporine in Newly Diagnosed TD-NSAA
NCT07548671Phase 3Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Apr 2026
- Primary completion
- Dec 2028
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of enarodustat in aplastic anemia, sponsored by Peking Union Medical College Hospital. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
enarodustat
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT07548671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07548671.